Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma

Clinical Cancer Research

Volumn 18, Issue 1, 2012, Pages 273-279

  Tsien, Christina I ^a   Brown, Doris ^a   Normolle, Daniel ^c   Schipper, Matthew ^a   Piert, Morand ^b   Junck, Larry ^b   Heth, Jason ^b   Gomez Hassan, Diana ^b   Ten Haken, Randall K ^a   Chenevert, Thomas ^b   Cao, Yue ^a   Lawrence, Theodore ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; COTRIMOXAZOLE; GADOLINIUM; METHIONINE C 11; PENTAMIDINE; STEROID; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE COURSE; DOSE RESPONSE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCYTOPENIA; PNEUMOCYSTIS PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION NECROSIS; SEPSIS; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY, INTENSITY-MODULATED; SALVAGE THERAPY; SURVIVAL RATE; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84855449737     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-2073     Document Type: Article

References (31)

1. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-9. (Pubitemid 19154322)
2. Garden AS, Maor MH, Yung WK, Bruner JM, Woo SY, Moser RP, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytoma. Radiother Oncol 1991;20:99-110.
3. Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, et al. Patterns of failure following high-dose 3-D conformal RT for highgrade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79-88. (Pubitemid 29065835)
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant TMZ for glioblastoma. N Engl J Med 2005;352:987-96 (Pubitemid 40349501)
5. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of RT with concomitant and adjuvant temozolomide versus RT alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66.
6. MacDonald SM, Ahmad S, Kachris S, Vogds BJ, DeRouen M, Gittleman AE, et al. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys 2007;8:47-60.
7. Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P, et al. Cerebral radiation necrosis: incidence, outcomes and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006;65:499-50.
8. 11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:64-74.
9. Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:511-9. (Pubitemid 41317169)
10. Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, et al. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 2000;48:43-52. (Pubitemid 30488211)
11. 11C-L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-70.
12. 18F-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study. Radiother Oncol 2009;93:586-92.
13. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994;18:110-8. (Pubitemid 24033867)
14. Torii K, Tsuyuguchi N, Kawabe J, Sunada I, Hara M, Shiomi S, et al. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med 2005;19:677-83. (Pubitemid 43175528)
15. Cao Y. Development of image software tools for radiation therapy assessment. Medical Phys 2005;32:2136.
16. Normolle D, Lawrence T. Designing dose-escalation trials with lateonset toxicities using the time-to-event continual reassessment method. J Clin Oncol 2006;24:4426-33. (Pubitemid 46630980)
17. CTCAEv3.0. The revised common toxicity criteria: version 3.0. [cited 2006]. Available from: http://ctep.info.nih.gov.
18. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80. (Pubitemid 20195640)
19. 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2009;73:479-85.
20. Villano JL, Collins CA, Manasanch EE, Ramaprasad C, van Besien K. Aplastic anaemia in a patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 2006;7:436-8.
21. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. Survival and failure patterns of high-grade gliomas after threedimensional conformal radiotherapy. J Clin Oncol 2002;20:1635-42 (Pubitemid 34260545)
22. Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, et al. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03. Int J Radiat Oncol Biol Phys 2009;73:699-708.
23. Souhami L, Seiferhold W, Brachman D. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004;60:853-60.
24. Selker RG, Shapiro WR, Burger P. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 2002;51:342-55.
25. 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med 2005;46:1948-58.
26. Torii K, Tsuyuguchi N, Kawabe J, Sunada I, Hara M, Shiomi S, et al. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med 2005;19:677-83 (Pubitemid 43175528)
27. 11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868-73
28. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999;22:210-14
29. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2011;29:142-8.
30. Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, et al. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 2010;16:2443-9.
31. Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009;75:156-163.